DEBRISOQUINE OXIDATION IN AN AUSTRALIAN POPULATION

被引：46

作者：

PEART, GF ^{[1
]}

BOUTAGY, J ^{[1
]}

SHENFIELD, GM ^{[1
]}

机构：

[1] ROYAL N SHORE HOSP,DEPT CLIN PHARMACOL,ST LEONARDS,NSW 2065,AUSTRALIA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 21卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1986.tb02827.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：465 / 471

页数：7

共 14 条

[1] THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE [J].

BERTILSSON, L ;

ABERGWISTEDT, A .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :388-390

[2]

DUSOUICH P, 1979, CLIN PHARMACOL THER, V26, P757

[3]

EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001

[4]

EVANS D A P, 1969, Journal of Medical Genetics, V6, P405, DOI 10.1136/jmg.6.4.405

[5] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[6]

IDLE JR, 1984, 2ND P WORLD C CLIN P, P148

[7] DEBRISOQUINE HYDROXYLATION CAPACITY - PROBLEMS OF ASSESSMENT IN 2 POPULATIONS [J].

INABA, T ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) :218-223

[8] PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN [J].

KUPFER, A ;

PREISIG, R .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :753-759

[9] A SIMPLE PHARMACOKINETIC METHOD FOR SEPARATING THE THREE ACETYLATION PHENOTYPES - A PRELIMINARY-REPORT [J].

LEE, EJD ;

LEE, LKH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (03) :375-378

[10] DETERMINATION OF DEBRISOQUINE AND ITS 4-HYDROXY METABOLITE IN BIOLOGICAL-FLUIDS BY GAS-CHROMATOGRAPHY WITH FLAME-IONIZATION AND NITROGEN-SELECTIVE DETECTION [J].

LENNARD, MS ;

SILAS, JH ;

SMITH, AJ ;

TUCKER, GT .

JOURNAL OF CHROMATOGRAPHY, 1977, 133 (01) :161-166

← 1 2 →